Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0VR5T
|
|||
Former ID |
DIB000058
|
|||
Drug Name |
BEPH
|
|||
Synonyms |
MDL-28314; N,N'-Bis[3-(ethylamino)propyl]-1,7-heptanediamine
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Discontinued in Phase 1 | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C17H40N4
|
|||
Canonical SMILES |
CCNCCCNCCCCCCCNCCCNCC
|
|||
InChI |
1S/C17H40N4/c1-3-18-14-10-16-20-12-8-6-5-7-9-13-21-17-11-15-19-4-2/h18-21H,3-17H2,1-2H3
|
|||
InChIKey |
WIOJAQYPAPCEMC-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 132004-62-7
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Polyamine unspecific (PLA) | Target Info | Modulator | [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003875) | |||
REF 2 | Antitumor activity of a novel synthetic polyamine analogue, N,N'-bis-[3-(ethylamino)-propyl]-1-7-heptane diamine: potentiation by polyamine oxidase inhibitors. Anticancer Res. 1990 Sep-Oct;10(5A):1281-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.